Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...

GLP-1 use significantly lowered risk for atrial fibrillation-related events for patients with diabetes, AF and obesity, with ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

You also have another product in your pipeline called Rejuva, which is a one-time gene therapy platform. Can you tell me about that and how it works? Yeah, we’re developing a smart GLP-1 gene therapy.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

The acronym GLP-1 has become an increasingly popular term in the health arena, especially in the context of weight loss.

Vivani Medical and Okava expand GLP-1 therapy research to dogs, aiming to advance long-acting treatments for cardiometabolic ...

Source Reference: Sundaram V, et al "TRANSFORM-AF: targeting metabolic therapy with GLP-1 receptor agonism for secondary prevention in atrial fibrillation" HRS 2025.

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...